- Home
- SWBI vs NBP Comparison
SWBI vs NBP Comparison
Compare SWBI & NBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SWBI | NBP |
|---|---|---|
| Founded | 1852 | 2014 |
| Country | United States | United States |
| Employees | N/A | 32 |
| Industry | Ordnance And Accessories | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 491.2M | 379.3M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | SWBI | NBP |
|---|---|---|
| Price | $14.01 | $3.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $14.00 | $9.00 |
| AVG Volume (30 Days) | 499.9K | ★ 608.5K |
| Earning Date | 06-04-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.69% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $474,661,000.00 | N/A |
| Revenue This Year | $2.62 | N/A |
| Revenue Next Year | $3.23 | N/A |
| P/E Ratio | $282.30 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.73 | $3.03 |
| 52 Week High | $14.51 | $5.19 |
Technical Indicators
Market Signals| Indicator | SWBI | NBP |
|---|---|---|
| Relative Strength Index (RSI) | 75.93 | 43.53 |
| Support Level | $7.91 | $3.04 |
| Resistance Level | N/A | $3.74 |
| Average True Range (ATR) | 0.40 | 0.27 |
| MACD | 0.22 | 0.02 |
| Stochastic Oscillator | 83.93 | 21.69 |
Price Performance
Historical ComparisonAbout SWBI Smith & Wesson Brands Inc.
Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.
About NBP NovaBridge Biosciences American Depositary Shares
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. It integrates scientific discovery with strategic planning and project management to move therapies from research toward potential patient use. Its pipeline includes Givastomig, VIS-101, Ragistomig and Uliledlimab.